Controlled release of gentamicin from calcium phosphate -: poly(lactic acid-co-glycolic acid) composite bone cement

被引:147
作者
Schnieders, Julia
Gbureck, Uwe
Thull, Roger
Kissel, Thomas
机构
[1] Univ Wurzburg, Dept Funct Mat Med & Dent, D-97070 Wurzburg, Germany
[2] Univ Marburg, Dept Pharmaceut & Biopharm, D-35032 Marburg, Germany
关键词
bone cement; hydroxyapatite; biodegradation; microspheres; antimicrobial; drug delivery;
D O I
10.1016/j.biomaterials.2006.03.032
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Modification of a self setting bone cement with biodegradable microspheres to achieve controlled local release of antibiotics without compromising mechanical properties was investigated. Different biodegradable microsphere batches were prepared from poly(lactic-co-glycolic acid) (PLGA) using a spray-drying technique to encapsulate gentamicin crobefate varying PLGA composition and drug loading. Microsphere properties such as surface morphology, particle size and antibiotic drug release profiles were characterized. Microspheres were mixed with an apatitic calcium phosphate bone cement to generate an antibiotic drug delivery system for treatment of bone defects. All batches of cement/microsphere composites showed an unchanged compressive strength of 60 MPa and no increase in setting time. Antibiotic release increased with increasing drug loading of the microspheres up to 30% (w/w). Drug burst of gentamicin crobefate in the microspheres was abolished in cement/microsphere composites yielding nearly zero order release profiles. Modification of calcium phosphate cements using biodegradable microspheres proved to be an efficient drug delivery system allowing a broad range of 10-30% drug loading with uncompromised mechanical properties. (c) 2006 Elsevier Ltd. All rights reserved.
引用
收藏
页码:4239 / 4249
页数:11
相关论文
共 40 条
[11]   TREATMENT OF EXPERIMENTAL OSTEOMYELITIS WITH ANTIBIOTIC-IMPREGNATED BONE-GRAFT SUBSTITUTE [J].
CORNELL, CN ;
TYNDALL, D ;
WALLER, S ;
LANE, JM ;
BRAUSE, BD .
JOURNAL OF ORTHOPAEDIC RESEARCH, 1993, 11 (05) :619-626
[12]   In vitro cytotoxicity testing of polycations: influence of polymer structure on cell viability and hemolysis. [J].
Fischer, D ;
Li, YX ;
Ahlemeyer, B ;
Krieglstein, J ;
Kissel, T .
BIOMATERIALS, 2003, 24 (07) :1121-1131
[13]   PLGA microspheres for the ocular delivery of a peptide drug, vancomycin using emulsification/spray-drying as the preparation method: in vitro/in vivo studies [J].
Gavini, E ;
Chetoni, P ;
Cossu, M ;
Alvarez, MG ;
Saettone, MF ;
Giunchedi, P .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2004, 57 (02) :207-212
[14]   Ionic modification of calcium phosphate cement viscosity. Part I: hypodermic injection and strength improvement of apatite cement [J].
Gbureck, U ;
Barralet, JE ;
Spatz, K ;
Grover, LM ;
Thull, R .
BIOMATERIALS, 2004, 25 (11) :2187-2195
[15]   Surface properties of calcium phosphate particles for self setting bone cements [J].
Gbureck, U ;
Probst, J ;
Thull, R .
BIOMOLECULAR ENGINEERING, 2002, 19 (2-6) :51-55
[16]  
GIUNCHEDI P, 1995, STP PHARMA SCI, V5, P276
[17]   Improvement of perineal wound healing by local administration of gentamicin-impregnated collagen fleeces after abdominoperineal excision of rectal cancer [J].
Gruessner, U ;
Clemens, M ;
Pahlplatz, PV ;
Sperling, P ;
Witte, E ;
Rosen, HR .
AMERICAN JOURNAL OF SURGERY, 2001, 182 (05) :502-509
[18]   The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices [J].
Jain, RA .
BIOMATERIALS, 2000, 21 (23) :2475-2490
[19]   Evaluation of an in situ setting injectable calcium phosphate as a new carrier material for gentamicin osteomyelitis: Studies in the treatment of chronic in vitro and in vivo [J].
Joosten, U ;
Joist, A ;
Frebel, T ;
Brandt, B ;
Diederichs, S ;
von Eiff, C .
BIOMATERIALS, 2004, 25 (18) :4287-4295
[20]   Osteomyelitis [J].
Lew, DP ;
Waldvogel, FA .
LANCET, 2004, 364 (9431) :369-379